HCG executes definitive agreements for business combination of Triesta with Strand

05 Jan 2018 Evaluate

Healthcare Global Enterprises (HCG) has executed definitive agreements for the business combination of its Triesta Sciences business unit (Triesta) with Strand Life Sciences (Strand).

Strand, established in 2000 as a spin-off from the Indian Institute of Science, is a bioinformatics company working with global technology vendors and research laboratories, and is the leader in genomic testing for cancer and inherited diseases in India. Triesta, a unit of HCG, offers comprehensive molecular diagnostics services and research services in the field of oncology.

The combination of Triesta and Strand creates an integrated platform with end to end capabilities in precision medicine - proprietary analytics, clinical research, access to the HCG biorepository, genomic technologies, assay development and validation and a network of laboratories offering a broad menu of tests.

HealthCare Global Enterprises (HCG) is the largest provider of cancer care in India. Through its network of 15 comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.



HealthcareGlobal Share Price

498.45 -0.15 (-0.03%)
15-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6694.40
Max Healthcare Inst 1039.35
Narayana Hrudayalay 1287.85
Aster DM Healthcare 489.85
Global Health 1023.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.